Chemotherapy
Chemotherapy is one of the most common treatment options used for Hodgkin’s lymphoma. Chemotherapy involves using powerful anti-cancer drugs that are administered orally or through an IV to destroy cancer cells throughout the body. Depending on the stage of cancer and other factors, chemotherapy may be given alone or combined with other treatments like radiation therapy. Some common chemotherapy regimens used for Hodgkin’s lymphoma include ABVD, BEACOPP and Stanford V. The ABVD regimen contains doxorubicin, bleomycin, vinblastine and dacarbazine while BEACOPP includes bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone. Stanford V chemotherapy uses mechlorethamine, doxorubicin, vinblastine, vincristine, bleomycin and etoposide. Chemotherapy is usually administered in cycles with each cycle lasting a few weeks. Patients receive chemotherapy for several cycles depending upon their response and stage of disease. While chemotherapy is very effective at treating Hodgkin’s lymphoma, it also has side effects like fatigue, nausea, vomiting, hair loss, reduced immunity etc. Proper care needs to be taken during chemotherapy treatment.
Radiation Therapy
Radiation therapy uses high-energy x-rays or other particles to destroy cancer cells and shrink tumours. In Hodgkin's Lymphoma Treatment, radiation therapy is mainly used after chemotherapy to destroy any remaining cancer cells and reduce the risk of recurrence. It can also be given as the primary treatment for early-stage disease. During radiation therapy, a careful treatment plan is designed to deliver precise radiation doses to target areas in the lymph nodes and spare nearby normal tissues. The most common approach is involved-field radiation therapy where only the lymph node areas initially involved by the cancer are targeted. Advanced techniques like intensity-modulated radiation therapy help deliver more precise radiation doses. Typical treatment involves giving radiation therapy daily, 5 days a week for 2-4 weeks. Side effects are usually mild and temporary ranging from skin changes and fatigue. Special care needs to be taken of the exposed area during and after radiation therapy.
Stem Cell Transplant
For patients with relapsed or advanced stage Hodgkin's Lymphoma Treatment that has not responded well to other treatment options, an autologous or allogeneic stem cell transplant may be recommended. In an autologous transplant, the patient’s own healthy stem cells are collected from their bloodstream before administering high-dose chemotherapy. This high-dose chemo is more powerful than standard therapy in destroying cancer cells but also has high toxicity. So the collected stem cells are then put back into the patient's bloodstream to help regenerate the bone marrow after chemotherapy ends. In an allogeneic transplant, stem cells from a donor is used instead. High-dose chemotherapy with or without total body irradiation is then given along with anti-cancer drugs which destroy any remaining cancer cells and also the patient's immune system. The donor stem cells then help reboot the patient's bone marrow and immune system. While stem cell transplants are very effective treatment options with long-term remissions, they are also associated with high risks of side effects and complications requiring close medical management in hospital.
Immunotherapy
Immunotherapy is a type of treatment that utilizes the body's own immune system to recognize and destroy cancer cells. For Hodgkin’s lymphoma, the main immunotherapy drug approved is brentuximab vedotin which is an antibody-drug conjugate. It attaches an anti-CD30 chemotherapy drug ( MMAE) to an antibody that binds to CD30 found on Hodgkin’s lymphoma cells. This helps deliver the chemotherapy directly to the cancer cells while sparing normal cells. It is usually given with chemotherapy like AVD. Brentuximab vedotin has significantly improved response rates and survival in relapsed/refractory Hodgkin’s lymphoma. Other immunotherapies under investigation include checkpoint inhibitors like PD-1 inhibitors nivolumab and pembrolizumab which remove brakes on immune system T cells to better attack cancer cells. Overall, immunotherapies have fewer side effects than chemotherapy but require close oversight by oncology team. They are showing great promise either alone or combined with other treatments.
Watchful Waiting
In some cases of early stage Hodgkin’s lymphoma with favourable features, an approach called active surveillance or watchful waiting may be advised initially instead of immediate treatment. Here the patient is closely monitored with frequent medical exams and scans for signs of lymphoma growth or progression. Treatment will be started promptly if needed. This approach aims to spare patients with less aggressive disease from short and long-term effects of therapies if their cancer remains stable or in remission on its own for some period. The risks of disease progression must be carefully weighed against over-treatment concerns for patients eligible for active surveillance. Close ongoing assessment involving multidisciplinary experts is very important while on watchful waiting approach. Treatment is promptly started if any signs of progression appear on surveillance.
Surgical Options
While surgery is not a primary treatment option Hodgkin’s lymphoma, it does have some role. A biopsy is needed for initial diagnosis to examine cells under microscope and get clear confirmation of Hodgkin’s lymphoma. For certain early-stage disease, some lymph nodes may be surgically removed to help determine stage and prognosis more accurately. For advanced disease, surgery has a very limited role and is usually not advised. In rare cases of drug-resistant disease or if tumours develop in unusual locations like brain, minimally-invasive surgeries may be done to debulk large masses before or after other treatments. For most patients, non-surgical options like chemotherapy, radiation therapy or stem cell transplant offer more comprehensive treatment approach without need for surgery. Overall surgical option needs careful evaluation on case-by-case basis by lymphoma specialists.
Hodgkin's Lymphoma Treatment involve chemotherapy, radiation therapy, stem cell transplant, immunotherapy and in some cases active surveillance or surgery. Choice of treatment depends on various disease factors like stage, risk factors, organ involvement, response to initial therapy, patient characteristics and preferences. A multidisciplinary team of oncologists closely collaborates to determine the best individualized treatment plan. With advances in treatment options, the five year survival rate for Hodgkin’s lymphoma now exceeds 85 percent for most stages. Early detection and treatment is key to optimizing outcomes. Ongoing care and surveillance is also important to monitor response and watch for any recurrences.
Get more insights on Hodgkin's Lymphoma Treatment
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comentarios